tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumRatingsHold Rating on Boundless Bio Inc.: Awaiting Clinical Validation of Innovative Therapies
5M ago
Boundless Bio price target lowered to $4 from $5 at H.C. Wainwright
Premium
The Fly
Boundless Bio price target lowered to $4 from $5 at H.C. Wainwright
5M ago
Premium
Company Announcements
Boundless Bio Reports Q2 2025 Financial Results
5M ago
PremiumCompany AnnouncementsBoundless Bio Inc. Reports Q1 2025 Financial Results
7M ago
Premium
Ratings
Hold Rating Issued for Boundless Bio Inc. Amid Strategic Setbacks and Delayed Program Validations
7M ago
Boundless Bio downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Boundless Bio downgraded to Market Perform from Outperform at Leerink
7M ago
Boundless Bio files $400M mixed securities shelf
PremiumThe FlyBoundless Bio files $400M mixed securities shelf
9M ago
Premium
Company Announcements
Boundless Bio’s 2024 Financial Results and Strategic Progress
9M ago
Boundless Bio reports Q4 EPS (74c) vs ($9.76) last year
Premium
The Fly
Boundless Bio reports Q4 EPS (74c) vs ($9.76) last year
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100